Details of the Drug Reposition

General Information of This Drug (ID: DM66DIW)

Drug Name	SNS01-T DM66DIW

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Diffuse large B-cell lymphoma	DISSACK3	2A81	Phase 1/2	[1]
Mantle cell lymphoma	DISFREOV	2A85.5	Phase 1/2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01435720) Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL). U.S. National Institutes of Health.